Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HARVARD BIOSCIENCE INC Director's Dealing 2013

Jan 14, 2013

34975_dirs_2013-01-14_6c0e8e7c-fb0a-416e-ac90-716f35e0a632.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2013-01-14

Reporting Person: LUSCINSKI SUSAN M (Chief Operating Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-01-14 Common Stock F 11475 $4.38 Disposed 426180 Direct

Footnotes

F1: The shares were disposed to satisfy Ms. Luscinski's tax withholding obligation in connection with deferred stock awards granted to Ms. Luscinski on June 4, 2010, June 2, 2011 and June 1, 2012 all of which vested in part on January 1, 2013.

F2: Includes (a) a deferred stock award of 16,700 restricted stock units which will vest on Jan1, 2014; (b) a deferred stock award of 9,374 restricted stock units which vest in equal installments on Jan 1, 2014 and Jan 1, 2015; (c) a deferred stock award of 30,954 restricted stock units which vest in equal installments on Jan 1, 2014, Jan 1, 2015 and Jan 1, 2016; and (d) 369,152 shares of common stock held by Ms. Luscinski.